Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2007
10/24/2007CN101058832A Method for detecting growth hormone variations in humans, the variations and their uses
10/24/2007CN101058819A FNAi carrier and application thereof
10/24/2007CN101058815A Deletion mutant of a set of hepatitis B HBx gene and application thereof
10/24/2007CN101058810A Amphioxus uncoupling protein gene and application thereof
10/24/2007CN101058809A Humanization modified rat ING4 gene and adenovirus expression vectors thereof
10/24/2007CN101058808A Breast cancer relevant p69 gene, coding protein and application thereof
10/24/2007CN101058604A FK gene, coding protein and application thereof
10/24/2007CN101057976A Substances for preventing and treating autoimmune diseases
10/24/2007CN101057975A Cocktail vaccine for anti immune tolerance and immunodeficiency virus and its application
10/24/2007CN101057974A Simulated virus type rotavirus gene vaccine and its preparation method
10/24/2007CN101057970A Therapeutic vaccine for Myostatin specific antibody and its preparation method
10/24/2007CN100344646C Oligonucleotide-containing pharmacological compositions and their use
10/24/2007CN100344331C Targeted small interference RNA formulation for preventing and treating Hepatitis C and its preparation method
10/24/2007CN100344330C Targeted small interference RNA formulation for treating viral Hepatitis B and its preparation
10/24/2007CN100344329C Immune stimulating and controlling composition comprising bacterial chromosomal DNA fragments and non-toxic lipopolysaccharides
10/23/2007US7285654 Stimulus-inducible protein kinase complex and methods of use therefor
10/23/2007US7285639 Antibody to telomerase reverse transcriptase
10/23/2007US7285542 Hyperthermic inducible expression vectors for gene therapy and methods of use thereof
10/23/2007US7285541 Antisense treatments for melanoma by inhibition of clusterin, also known as testosterone-repressed prostate message-2, for example by administration of antisense oligonucleotides specific for clusterin
10/23/2007US7285540 hepatocyte growth factor gene as drug; topical applying ; side effect reduction; cardiovascular disorders
10/23/2007US7285539 Using fusion proteins comprising HCV NS3, NS4, NS5a, and NS5b polypeptides and polynucleotides encoding them
10/23/2007US7285538 Gene therapy; mutant Dna
10/23/2007US7285535 Administering TIRAP to block Toll/Interleukin-1 Receptor Adaptor Protein signaling in a cell; for treatment of inflammation and inducing or affecting immune response.
10/23/2007US7285527 Tumor radiosensitization using gene therapy
10/23/2007US7285414 Viruses targeted to hypoxic cells and tissues
10/23/2007US7285400 High bone mass gene of 11q13.3
10/23/2007US7285390 Screening methods for identifying compounds which decrease HIV entry into a cell
10/23/2007US7285383 Cell with recombinant nucleic acid comprisinga hepatitis C virus internal ribosome etry site (IRES) operably linked to a polynucleotide encoding a reporter protein; and a test compound; drug screening for viricides; determining if translation is allowed or prevented by interaction with drug or cell
10/23/2007US7285381 Insertion in amino acid sequence of structural protein; purification, mutagenesis, genetic engineering; higher titers; gene therapy, cell transformation
10/23/2007US7285282 Mucin peptide with immunoenhancing properties
10/23/2007US7285276 Polynucleotide sequence for Chlamydia pneumonia; therapy, prevention of Chlamydia infections
10/23/2007US7285265 Stable adenoviral vectors and methods for propagation thereof
10/23/2007CA2391098C Recombinant .alpha.-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
10/23/2007CA2272130C Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (lag-3)
10/23/2007CA2217780C Polyether nucleic acids
10/23/2007CA2206179C Vectors for tissue-specific replication
10/18/2007WO2007118245A2 Methods and compositions related to adenoassociated virus-phage particles
10/18/2007WO2007117686A2 Stabilized immune modulatory rna (simra) compounds for tlr7 and tlr8
10/18/2007WO2007117680A2 Methods and compositions for treating bacterial infection
10/18/2007WO2007117472A2 Adult bone marrow cell transplantation to testes creation of transdifferentiated testes germ cells, leydig cells and sertoli cells
10/18/2007WO2007117038A1 Prophylactic/therapeutic agent for cancer
10/18/2007WO2007116965A1 Fine particle containing graft polymer and calcium compound
10/18/2007WO2007116276A2 Integrin binding rgd-lipopeptides with gene transfer activities
10/18/2007WO2007115414A1 Modified h2 relaxin for tumor suppression
10/18/2007WO2007087580A3 Y134.5 deficient hsv comprising a coding region of a member of the mapk pathway for the treatment of a cell proliferation disorder
10/18/2007WO2003061560A3 Replication competent dual-ad vectors for vaccine and immunotherapy applications
10/18/2007WO2002010198A3 Polynucleotides and polypeptides
10/18/2007US20070244067 drug delivering polynucleotides to skeletal muscle cells in a limb by inserting an injector into an artery in the limb; impeding blood flow to the surface of the skin; and injecting a solution containing the polynucleotides; treating Muscular Dystrophy patient
10/18/2007US20070244066 Method for preventing or treating neuropathic pain
10/18/2007US20070244050 Peptides as solubilizing excipients for transforming growth factor beta proteins
10/18/2007US20070244043 Recombinant E-selectin made in insect cells
10/18/2007US20070244041 Peptide Yy Analogues
10/18/2007US20070243242 Compositions for treating hearing loss and methods of use thereof
10/18/2007US20070243224 Methods and compositions for treatment of lesioned sites of body vessels
10/18/2007US20070243209 Compositions and methods for prevention and treatment of fungal diseases
10/18/2007US20070243197 Dendrite Cells Transduced with Recombinant Adenovirus Advcea Which Generate Cea-Specific Cytotoxic T Lymphocytes, Vaccine and Pharmaceutical Composition Comprising the Same
10/18/2007US20070243195 Vaccine against streptococci
10/18/2007US20070243176 Human genes and gene expression products
10/18/2007US20070243171 Biological Cell Culture, Cell Culture Media and Therapeutic Use of Biological Cells
10/18/2007US20070243168 Minigene expression cassette
10/18/2007US20070243167 Novel Herpes Simplex Viruses
10/18/2007US20070243157 A polyethylenimine block polymer with a bis(acryloxyethyl)amine N-substituted by a fatty acid or cholesterol derivative, conjugated with a nucleic acid or siRNA; improved drug delivery and bioavailability
10/18/2007US20070243139 A dimer of two polypeptides having specificity andreceptivity for different epitopes on a protein-tyrosinekinase receptor; linked by spacers; synergistic; contrast agents for radition imaging and therapy; biodrugs; hepatocyte growth factor receptor/cMET complex target; antitumor, -carcinogenic agents
10/18/2007US20070243131 Biopolymer system for tissue sealing
10/18/2007US20070243130 Biopolymer system for tissue sealing
10/18/2007DE10045123B4 Das C. albicans TEC1 GEN(CaTEC1) und das kodierte Tec1p Protein The C. albicans TEC1 GEN (CaTEC1) and the encoded protein Tec1p
10/18/2007CA2649182A1 Methods and compositions related to adenoassociated virus-phage particles
10/18/2007CA2648718A1 Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
10/17/2007EP1845164A2 Promoters for expression in modified vaccinia virus ankara
10/17/2007EP1845163A2 Adeno-associated virus serotype l nucleic acid sequences, vetors and host cells containing same
10/17/2007EP1845162A1 DNA sequences having anti-repressor activity
10/17/2007EP1844772A1 Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications
10/17/2007EP1844763A1 Percutaneously absorbable preparation, percutaneously absorbable preparation holding sheet, and percutaneously absorbable preparation holding equipment
10/17/2007EP1843791A1 Treatment of degenerative diseases with the x-linked inhibitor of apoptosis
10/17/2007EP1843773A1 Method and composition for treatment of neoplasms
10/17/2007EP1699398A4 Enhancement of immune responses
10/17/2007EP1567662A4 Caged sensors, regulators and compounds and uses thereof
10/17/2007EP1546216B1 Methods of drug delivery using sulphated chitinous polymers
10/17/2007EP1427758B1 Compositions and methods of treating diabetes
10/17/2007EP1311289B1 Vaccines containing ribavirin
10/17/2007EP1123387B1 Mn gene and protein
10/17/2007EP1092018B1 Kv6.2, A VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT
10/17/2007EP1084230B1 Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells
10/17/2007EP1076710B1 Factors affecting tumor necrosis factor receptor releasing enzyme activity
10/17/2007EP1002103B1 A human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereof
10/17/2007EP0862442A4 Methods for diagnosis and treatment of bloom's syndrome
10/17/2007CN101056976A Defective influenza virus particles
10/17/2007CN101054596A Recombination adenovirus for curing overexpression proto-oncogene neu/erbB2 malignancy
10/17/2007CN101054591A Oligonucleotide for targeted activation of chronic granulocyte leukaemia protein kinase PKR and application thereof
10/17/2007CN101054584A 鱼类干扰素基因及其用途 Fish interferon gene and its use
10/17/2007CN101054582A A-type kreotoxin receptor combination region Hc, coding protein and application thereof
10/17/2007CN101054578A Hairpin RNA and application thereof
10/17/2007CN101054577A A siRNA and expression carrier capable of inhibiting Bax gene expression and application of the same used as virus hepatitis B treatment medicament
10/17/2007CN101054419A Vectors with modified protease-dependent tropism
10/17/2007CN101054413A Tumor correlated albumen, coding gene and application thereof
10/17/2007CN101053664A Construction and expression for tumor immunity synergistic carrier pBVIM
10/17/2007CN101053663A Replication competent type DNA vaccine carrier pSFVax1-IRES and its construction method
10/17/2007CN101053573A Compositions and methods based on VEGF antisense oligonucleotides
10/17/2007CN100343393C Central airway administration for systemic delivery of therapeutics
10/17/2007CN100342915C Stem cell target-locating and enriching method
1 ... 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 ... 870